FANCM and RECQL truncating mutations characterized by case-control analyses, following their initial involvement in breast cancer susceptibility via a whole-exome sequencing approach. List of FANCM and RECQL truncation mutations identified by case-control analyses and corresponding references. (DOCX 19Â kb
Additional file 2: Supplementary Methods, Supplementary Table S5, Supplementary Table S6, Supplement...
List with all genes (exome-wide) presenting a PDAV in at least two BC patients and the number of con...
Tables S2-S5. Supplementary tables including linkage disequilibrium between top SNPs and previously ...
BACKGROUND: FANCM and RECQL have recently been reported as breast cancer susceptibility genes and it...
Additional file 4: Supplementary Table 1. Total number of potentially pathogenic variants discovered...
Abstract Background FANCM and RECQL have recently been reported as breast cancer susceptibility gene...
List with PDAVs detected in 54âBC patients located in genes linked to (hereditary) cancer and/or h...
This file includes two tables regarding baseline characteristics of study participants, possibly pat...
Breast cancer (BC) patients considered for the study, their age at diagnosis and the number of affec...
PDAVs found in the CAPG of the 120 control samples and their occurrence in the general population. (...
Taqman assays used for CNV assessment at 7 gene loci. Table S3. Cancer-predisposing genes disrupted ...
Types and number of variants detected (exome- and CAGP-wide) before and after variant filtration in ...
Selected and sequenced regions. All regions have previously been identified as breast cancer GWAS su...
BC patients vs. controls variant types enrichment in exome- and CAGP-wide. (XLSX 10 kb
Deleterious BRCA1/2 germline mutations in Pakistani patients with TNBC. (DOCX 24Â kb
Additional file 2: Supplementary Methods, Supplementary Table S5, Supplementary Table S6, Supplement...
List with all genes (exome-wide) presenting a PDAV in at least two BC patients and the number of con...
Tables S2-S5. Supplementary tables including linkage disequilibrium between top SNPs and previously ...
BACKGROUND: FANCM and RECQL have recently been reported as breast cancer susceptibility genes and it...
Additional file 4: Supplementary Table 1. Total number of potentially pathogenic variants discovered...
Abstract Background FANCM and RECQL have recently been reported as breast cancer susceptibility gene...
List with PDAVs detected in 54âBC patients located in genes linked to (hereditary) cancer and/or h...
This file includes two tables regarding baseline characteristics of study participants, possibly pat...
Breast cancer (BC) patients considered for the study, their age at diagnosis and the number of affec...
PDAVs found in the CAPG of the 120 control samples and their occurrence in the general population. (...
Taqman assays used for CNV assessment at 7 gene loci. Table S3. Cancer-predisposing genes disrupted ...
Types and number of variants detected (exome- and CAGP-wide) before and after variant filtration in ...
Selected and sequenced regions. All regions have previously been identified as breast cancer GWAS su...
BC patients vs. controls variant types enrichment in exome- and CAGP-wide. (XLSX 10 kb
Deleterious BRCA1/2 germline mutations in Pakistani patients with TNBC. (DOCX 24Â kb
Additional file 2: Supplementary Methods, Supplementary Table S5, Supplementary Table S6, Supplement...
List with all genes (exome-wide) presenting a PDAV in at least two BC patients and the number of con...
Tables S2-S5. Supplementary tables including linkage disequilibrium between top SNPs and previously ...